Quarterly report · Q2
4521.TEDINET S100S89K
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥36.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥73.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥36.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥5.5bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥8.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥5.7bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥8.7bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.6bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥5.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥8.2bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥4.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥5.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥4.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥6.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥171.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥166.3bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥167.3bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.9bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥29.5bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥140.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥136.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥140.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥55.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥59.6bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥70.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥74.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥75.5bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥74.6bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥245m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥9.3bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥6.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.8bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.0bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥4.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.18 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥41.29 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.8 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥158.34 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.45 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 82.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.9% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 83.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 18
| Segment | Item | Period | Value |
|---|---|---|---|
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥35.0bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥35.0bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥4.9bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥661m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥36.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥5.5bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥35.6bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥35.6bn |
| jpcrp040300-q2r_E00935-000Medicinereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥7.6bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E00935-000Real Estatereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥616m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥36.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥36.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥8.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 501
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of intangible assets inv cf | Prior1YTDDuration | -145000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -186000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 5000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 8000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -158000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -229000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -1410000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -1141000000 | JPY |
| Net decrease increase in treasury stock fin cf | Prior1YTDDuration | -1339000000 | JPY |
| Net decrease increase in treasury stock fin cf | CurrentYTDDuration | 0 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -2835000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -2813000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -4174000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -2813000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | － | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | － | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 842000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | -4199000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 74625000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 74260000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 75467000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 70060000000 | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_jpcrp040300-q2r_E00935-000MedicineReportableSegmentsMember | 34649000000 | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_jpcrp040300-q2r_E00935-000RealEstateReportableSegmentsMember | － | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 34649000000 | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales of finished goods and merchandise | Prior1YTDDuration | 34649000000 | JPY |
| Royalty | Prior1YTDDuration_jpcrp040300-q2r_E00935-000MedicineReportableSegmentsMember | 951000000 | JPY |
| Royalty | Prior1YTDDuration_jpcrp040300-q2r_E00935-000RealEstateReportableSegmentsMember | － | JPY |
| Royalty | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 951000000 | JPY |
| Royalty | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Royalty | Prior1YTDDuration | 951000000 | JPY |
| Other income | Prior1YTDDuration_jpcrp040300-q2r_E00935-000MedicineReportableSegmentsMember | － | JPY |
| Other income | Prior1YTDDuration_jpcrp040300-q2r_E00935-000RealEstateReportableSegmentsMember | 1219000000 | JPY |
| Other income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 1219000000 | JPY |
| Other income | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Other income | Prior1YTDDuration | 1219000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00935-000MedicineReportableSegmentsMember | 35600000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E00935-000RealEstateReportableSegmentsMember | 1219000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 36819000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 36819000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00935-000MedicineReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E00935-000RealEstateReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00935-000MedicineReportableSegmentsMember | 35600000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E00935-000RealEstateReportableSegmentsMember | 1219000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 36819000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |